Year |
Citation |
Score |
2023 |
Piorecka K, Kurjata J, Gostynski B, Kazmierski S, Stanczyk WA, Marcinkowska M, Janaszewska A, Klajnert-Maculewicz B. Is acriflavine an efficient co-drug in chemotherapy? Rsc Advances. 13: 21421-21431. PMID 37465576 DOI: 10.1039/d3ra02608f |
0.695 |
|
2022 |
Piorecka K, Kurjata J, Stanczyk WA. Acriflavine, an Acridine Derivative for Biomedical Application: Current State of the Art. Journal of Medicinal Chemistry. 65: 11415-11432. PMID 36018000 DOI: 10.1021/acs.jmedchem.2c00573 |
0.675 |
|
2021 |
Piorecka K, Kurjata J, Stanczyk WA. Nanoarchitectonics: Complexes and Conjugates of Platinum Drugs with Silicon Containing Nanocarriers. An Overview. International Journal of Molecular Sciences. 22. PMID 34502173 DOI: 10.3390/ijms22179264 |
0.707 |
|
2020 |
Piorecka K, Kurjata J, Bak-Sypien I, Cypryk M, Steinke U, Stanczyk WA. Reasons for enhanced activity of doxorubicin on co-delivery with octa(3-aminopropyl)silsesquioxane. Rsc Advances. 10: 15579-15585. PMID 35495453 DOI: 10.1039/d0ra01319f |
0.681 |
|
2020 |
Piorecka K, Kurjata J, Stanczyk WA. Novel Polyhedral Silsesquioxanes [POSS(OH)] as Anthracycline Nanocarriers-Potential Anticancer Prodrugs. Molecules (Basel, Switzerland). 26. PMID 33374161 DOI: 10.3390/molecules26010047 |
0.688 |
|
2020 |
Piorecka K, Janaszewska A, Majkowska M, Marcinkowska M, Kurjata J, Kazmierski S, Radzikowska-Cieciura E, Kost B, Sowinski P, Klajnert-Maculewicz B, Stanczyk WA. Hydrophilic Polyhedral Oligomeric Silsesquioxane, POSS(OH), as a Complexing Nanocarrier for Doxorubicin and Daunorubicin. Materials (Basel, Switzerland). 13. PMID 33287168 DOI: 10.3390/ma13235512 |
0.694 |
|
2020 |
Piorecka K, Smith D, Kurjata J, Stanczyk M, Stanczyk WA. Synthetic routes to nanoconjugates of anthracyclines. Bioorganic Chemistry. 96: 103617. PMID 32014639 DOI: 10.1016/J.Bioorg.2020.103617 |
0.605 |
|
2020 |
Piorecka K, Kurjata J, Bak-Sypien I, Cypryk M, Steinke U, Stanczyk WA. Reasons for enhanced activity of doxorubicin on co-delivery with octa(3-aminopropyl)silsesquioxane Rsc Advances. 10: 15579-15585. DOI: 10.1039/D0Ra01319F |
0.624 |
|
2018 |
Piorecka K, Kurjata J, Stanczyk M, Stanczyk WA. Synthetic routes to nanomaterials containing anthracyclines: noncovalent systems. Biomaterials Science. PMID 30140825 DOI: 10.1039/C8Bm00739J |
0.695 |
|
2017 |
Sobierajska E, Konopka M, Janaszewska A, Piorecka K, Blauz A, Klajnert-Maculewicz B, Stanczyk M, Stanczyk WA. Unusual Enhancement of Doxorubicin Activity on Co-Delivery with Polyhedral Oligomeric Silsesquioxane (POSS). Materials (Basel, Switzerland). 10. PMID 28772919 DOI: 10.3390/Ma10050559 |
0.657 |
|
2017 |
Piorecka K, Stanczyk W, Florczak M. NMR analysis of antitumor drugs: Doxorubicin, daunorubicin and their functionalized derivatives Tetrahedron Letters. 58: 152-155. DOI: 10.1016/J.Tetlet.2016.11.118 |
0.679 |
|
2016 |
Piorecka K, Radzikowska E, Kurjata J, Rozga-Wijas K, Stanczyk WA, Wielgus E. Synthesis of the first POSS cage-anthracycline conjugates: Via amide bonds New Journal of Chemistry. 40: 5997-6000. DOI: 10.1039/C6Nj00347H |
0.652 |
|
Show low-probability matches. |